MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 535755 | Name: BM 27

Description:

WARNING: This product is for research use only, not for human or veterinary use.

BM 27 is a bioactive chemcial.

Chemical Structure

BM 27
BM 27
CAS#143214-66-8

Theoretical Analysis

MedKoo Cat#: 535755

Name: BM 27

CAS#: 143214-66-8

Chemical Formula: C20H32N4O3S

Exact Mass: 408.2195

Molecular Weight: 408.56

Elemental Analysis: C, 58.80; H, 7.90; N, 13.71; O, 11.75; S, 7.85

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
BM 27; BM-27; BM27
IUPAC/Chemical Name
3-Pyridinesulfonamide, 4-(cycloheptylamino)-N-((cycloheptylamino)carbonyl)-
InChi Key
DWUSHNAJJBZDFT-UHFFFAOYSA-N
InChi Code
InChI=1S/C20H32N4O3S/c25-20(23-17-11-7-3-4-8-12-17)24-28(26,27)19-15-21-14-13-18(19)22-16-9-5-1-2-6-10-16/h13-17H,1-12H2,(H,21,22)(H2,23,24,25)
SMILES Code
O=S(C1=C(NC2CCCCCC2)C=CN=C1)(NC(NC3CCCCCC3)=O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 408.56 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Bohnert JA, Schuster S, Kern WV, Karcz T, Olejarz A, Kaczor A, Handzlik J, Kieć-Kononowicz K. Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay. Antimicrob Agents Chemother. 2016 Mar 25;60(4):1974-83. doi: 10.1128/AAC.01995-15. PMID: 26824939; PMCID: PMC4808168. 2: Berghoff AS, Schur S, Füreder LM, Gatterbauer B, Dieckmann K, Widhalm G, Hainfellner J, Zielinski CC, Birner P, Bartsch R, Preusser M. Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers. ESMO Open. 2016 Mar 16;1(2):e000024. doi: 10.1136/esmoopen-2015-000024. PMID: 27843591; PMCID: PMC5070252. 3: Renaudeau D, Brochain J, Giorgi M, Bocage B, Hery M, Crantor E, Marie- Magdeleine C, Archimède H. Banana meal for feeding pigs: digestive utilization, growth performance and feeding behavior. Animal. 2014 Apr;8(4):565-71. doi: 10.1017/S175173111400010X. Epub 2014 Feb 17. PMID: 24528838. 4: Masereel B, Lambert DM, Dogné JM, Poupaert JH, Delarge J. Anticonvulsant activity of pyrid-3-yl-sulfonyl ureas and thioureas. Epilepsia. 1997 Mar;38(3):334-7. doi: 10.1111/j.1528-1157.1997.tb01125.x. PMID: 9070596. 5: Masereel B, Dogné JM, Damas J, Nuhrich A, Varache-Lembège M, Fontaine J, Pochet L, Somers F, de Tullio P, Pirotte B, Delarge J. Pharmacomodulation of torasemide led to original diuretic, neuroprotective, anticonvulsant and antithrombotic drugs. J Pharm Belg. 1997 Jul-Aug;52(4):157-8. PMID: 9316342. 6: Nakano M, Kuriyama Y, Kawanishi Y, Toyama K. Clinical implication and prognostic significance of small lymphoma cells in the peripheral blood and bone marrow of B-cell non-Hodgkin's lymphomas. Leuk Lymphoma. 1993 Sep;11(1-2):119-27. doi: 10.3109/10428199309054739. PMID: 8220145. 7: Nakano M, Kawanishi Y, Kuge S, Kuriyama Y, Kuwabara S, Yaguchi M, Toyama K. Clinical and prognostic significance of monoclonal small cells in the peripheral blood and bone marrow of various B-cell lymphomas. Blood. 1992 Jun 15;79(12):3253-60. PMID: 1375848. 8: Chang YJ, Zhao XY, Huo MR, Luo XH, Huang XJ. [CD34 cells and T cell subsets in recombinant human granulocyte colony-stimulating factor primed bone marrow grafts from donors with different characteristics]. Zhonghua Xue Ye Xue Za Zhi. 2008 Aug;29(8):512-6. Chinese. PMID: 19112912. 9: Schönberger S, Niehues T, Meisel R, Bernbeck B, Laws HJ, Kögler G, Enzmann J, Wernet P, Göbel U, Dilloo D. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population. Klin Padiatr. 2004 Nov-Dec;216(6):356-63. doi: 10.1055/s-2004-832357. PMID: 15565551. 10: Maciejewski JP, Sloand EM, Sato T, Anderson S, Young NS. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone. Blood. 1997 Feb 15;89(4):1173-81. PMID: 9028939.